Terms ending in 2037
Every in-force patent on Accuray Incorporated's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,636,609 | Bremsstrahlung Target for Radiation Therapy System In force · High confidence | Accuray LLC | In force | High confidence | |
| US 10,307,614 | Systems and Methods for Selecting a Radiation Therapy Treatment Plan In force · High confidence | Accuray LLC | In force | High confidence | |
| US 10,569,105 | Radiation Based Treatment Beam Position Calibration and Verification In force · High confidence | Accuray LLC | In force | High confidence | |
| US 11,185,718 | Radiation Based Treatment Beam Position Calibration and Verification In force · High confidence | Accuray LLC | In force | High confidence | |
| US 11,648,423 | Radiation Based Treatment Beam Position Calibration and Verification In force · High confidence | Accuray LLC | In force | High confidence | |
| US 11,998,761 | Radiation Based Treatment Beam Position Calibration and Verification In force · High confidence | Accuray LLC | In force | High confidence | |
| US 10,342,996 | Online Angle Selection in Rotational Imaging and Tracking Systems In force · High confidence | Accuray LLC | In force | High confidence | |
| US 10,532,224 | Offline Angle Selection in Rotational Imaging and Tracking Systems In force · High confidence | Accuray LLC | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.